Skip to Content

R 196 (Clopidogrel bisulfate 75 mg (base))

Pill imprint R 196 has been identified as Clopidogrel bisulfate 75 mg (base).

Clopidogrel is used in the treatment of ischemic stroke; transient ischemic attack; peripheral arterial disease; ischemic stroke, prophylaxis; heart attack (and more), and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Clopidogrel 75 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Clopidogrel bisulfate 75 mg (base) R 196
Clopidogrel bisulfate 75 mg (base) R 196 Front
Clopidogrel bisulfate 75 mg (base) R 196 Back
Clopidogrel bisulfate
R 196
75 mg (base)
Prescription only
Drug Class:
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Dr.Reddy's Laboratories Limited
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (5 mPa.s)
polyethylene glycol 400
titanium dioxide

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.